SIC
LFCR icon

SJS Investment Consulting’s Lifecore Biomedical LFCR Stock Holding History

SJS Investment Consulting’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$672 Hold
128
– – ﹤0.01% 2165
2026
Q1 		$477 Sell
128
-46
-26% -$318 ﹤0.01% 1758
2025
Q4 		$1.42K Hold
174
– – ﹤0.01% 1203
2025
Q3 		$1.28K Hold
174
– – ﹤0.01% 934
2025
Q2 		$1.41K Hold
174
– – ﹤0.01% 693
2025
Q1 		$1.23K Buy
+174
New +$1.08K ﹤0.01% 932

Other funds holding LFCR

CA
CWC Advisors Lake Oswego, Oregon $225M AUM 23.94% 1-Year Est. Return
DT
DBA Trading Fort Lauderdale, Florida $199M AUM
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
MAA
Mraz Amerine & Associates Modesto, California $697M AUM 19.37% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

SJS Investment Consulting's LFCR Position: Q2 2026 in Review

SJS Investment Consulting held its Lifecore Biomedical (LFCR) position steady in Q2 2026 at 128 shares worth $672. The position accounts for ﹤0.01% of the portfolio, ranked #2165.

SJS Investment Consulting first reported a position in LFCR in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.42K in Q4 2025. 17 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • SJS Investment Consulting held 128 shares of Lifecore Biomedical worth $672 as of Q2 2026.
  • SJS Investment Consulting left its Lifecore Biomedical share count unchanged in Q2 2026.
  • Lifecore Biomedical made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2165 holding.
  • SJS Investment Consulting first reported a position in Lifecore Biomedical in Q1 2025 and has held it in 6 quarters since.
  • SJS Investment Consulting's Lifecore Biomedical position peaked at $1.42K in Q4 2025.
  • 17 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.